Literature DB >> 33746961

The Aryl Hydrocarbon Receptor as a Modulator of Anti-viral Immunity.

Maria Florencia Torti1, Federico Giovannoni2, Francisco Javier Quintana2, Cybele Carina García1.   

Abstract

The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor, which interacts with a wide range of organic molecules of endogenous and exogenous origin, including environmental pollutants, tryptophan metabolites, and microbial metabolites. The activation of AHR by these agonists drives its translocation into the nucleus where it controls the expression of a large number of target genes that include the AHR repressor (AHRR), detoxifying monooxygenases (CYP1A1 and CYP1B1), and cytokines. Recent advances reveal that AHR signaling modulates aspects of the intrinsic, innate and adaptive immune response to diverse microorganisms. This review will focus on the increasing evidence supporting a role for AHR as a modulator of the host response to viral infection.
Copyright © 2021 Torti, Giovannoni, Quintana and García.

Entities:  

Keywords:  DNA viruses; RNA viruses; aryl hydrocarbon receptor; host response; viral infections

Year:  2021        PMID: 33746961      PMCID: PMC7973006          DOI: 10.3389/fimmu.2021.624293

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  140 in total

1.  A Functional Aryl Hydrocarbon Receptor Genetic Variant, Alone and in Combination with Parental Exposure, is a Risk Factor for Congenital Heart Disease.

Authors:  Silvia Pulignani; Andrea Borghini; Cecilia Vecoli; Ilenia Foffa; Lamia Ait-Ali; Maria Grazia Andreassi
Journal:  Cardiovasc Toxicol       Date:  2018-06       Impact factor: 3.231

2.  Constitutive aryl hydrocarbon receptor signaling constrains type I interferon-mediated antiviral innate defense.

Authors:  Taisho Yamada; Hiromasa Horimoto; Takeshi Kameyama; Sumio Hayakawa; Hiroaki Yamato; Masayoshi Dazai; Ayato Takada; Hiroshi Kida; Debbie Bott; Angela C Zhou; David Hutin; Tania H Watts; Masahiro Asaka; Jason Matthews; Akinori Takaoka
Journal:  Nat Immunol       Date:  2016-04-18       Impact factor: 25.606

3.  Acromegaly Is More Severe in Patients With AHR or AIP Gene Variants Living in Highly Polluted Areas.

Authors:  S Cannavo; M Ragonese; S Puglisi; P D Romeo; M L Torre; A Alibrandi; C Scaroni; G Occhi; F Ceccato; D Regazzo; E De Menis; P Sartorato; G Arnaldi; L Trementino; F Trimarchi; F Ferrau
Journal:  J Clin Endocrinol Metab       Date:  2016-03-10       Impact factor: 5.958

4.  The p23 co-chaperone facilitates dioxin receptor signaling in a yeast model system.

Authors:  Marc B Cox; Charles A Miller
Journal:  Toxicol Lett       Date:  2002-03-24       Impact factor: 4.372

5.  Intake of dioxins and related compounds from food in the U.S. population.

Authors:  A Schecter; P Cramer; K Boggess; J Stanley; O Päpke; J Olson; A Silver; M Schmitz
Journal:  J Toxicol Environ Health A       Date:  2001-05-11

6.  Aryl hydrocarbon receptor activation during influenza virus infection unveils a novel pathway of IFN-gamma production by phagocytic cells.

Authors:  Haley Neff-LaFord; Sabine Teske; Timothy P Bushnell; B Paige Lawrence
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

7.  2,3,7,8-Tetrachlorodibenzo-p-dioxin is a possible activator of human cytomegalovirus replication in a human fibroblast cell line.

Authors:  Tsugiya Murayama; Masao Inoue; Taisei Nomura; Seiichiro Mori; Yoshito Eizuru
Journal:  Biochem Biophys Res Commun       Date:  2002-08-23       Impact factor: 3.575

Review 8.  AhR signalling and dioxin toxicity.

Authors:  Olivier Sorg
Journal:  Toxicol Lett       Date:  2013-11-12       Impact factor: 4.372

Review 9.  The role of chaperone proteins in the aryl hydrocarbon receptor core complex.

Authors:  John R Petrulis; Gary H Perdew
Journal:  Chem Biol Interact       Date:  2002-09-20       Impact factor: 5.192

Review 10.  Aryl Hydrocarbon Receptor: A New Player of Pathogenesis and Therapy in Cardiovascular Diseases.

Authors:  Tao Yi; Jinxia Wang; Kaixi Zhu; Yaoliang Tang; Shian Huang; Xiaorong Shui; Yuanlin Ding; Can Chen; Wei Lei
Journal:  Biomed Res Int       Date:  2018-06-10       Impact factor: 3.411

View more
  5 in total

Review 1.  Unbalanced IDO1/IDO2 Endothelial Expression and Skewed Keynurenine Pathway in the Pathogenesis of COVID-19 and Post-COVID-19 Pneumonia.

Authors:  Marco Chilosi; Claudio Doglioni; Claudia Ravaglia; Guido Martignoni; Gian Luca Salvagno; Giovanni Pizzolo; Vincenzo Bronte; Venerino Poletti
Journal:  Biomedicines       Date:  2022-06-06

2.  Hexokinase 2 is a transcriptional target and a positive modulator of AHR signalling.

Authors:  Manon Watzky; Solène Huard; Ludmila Juricek; Julien Dairou; Caroline Chauvet; Xavier Coumoul; Anne Letessier; Benoit Miotto
Journal:  Nucleic Acids Res       Date:  2022-06-10       Impact factor: 19.160

3.  AMP5A modulates Toll-like receptors 7 and 8 single-stranded RNA immune responses in PMA-differentiated THP-1 and PBMC.

Authors:  Gregory Thomas; Kristen Hirter; Elizabeth Frederick; Melissa Hausburg; Raphael Bar-Or; Yetti Mulugeta; Michael Roshon; Charles Mains; David Bar-Or
Journal:  Transl Med Commun       Date:  2022-03-03

Review 4.  Hypothesis: Emerging Roles for Aryl Hydrocarbon Receptor in Orchestrating CoV-2-Related Inflammation.

Authors:  Tiziana Guarnieri
Journal:  Cells       Date:  2022-02-13       Impact factor: 6.600

5.  Antiviral Property of the Fungal Metabolite 3-O-Methylfunicone in Bovine Herpesvirus 1 Infection.

Authors:  Filomena Fiorito; Claudia Cerracchio; Maria Michela Salvatore; Francesco Serra; Alessia Pucciarelli; Maria Grazia Amoroso; Rosario Nicoletti; Anna Andolfi
Journal:  Microorganisms       Date:  2022-01-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.